.png)
If President Trump's threat to impose tariffs on pharmaceutical products goes through, it would have severe consequences for industry R&D efforts, according to a Bayer (OTCPK:BAYZF) pharma executive.
"Every dollar we spend on tariffs is a dollar we can’t spend
English (US) ·